Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/23/2025 | Q3 | -- | $7.6B | $0.42 | -- | -- |
| 07/24/2025 | Q2 | -- | $7.4B | $0.50 | -- | -- |
| 04/24/2025 | Q1 | -- | $7B | $0.55 | -- | -- |
| 03/04/2025 | Q4 | -- | $7.7B | $0.57 | -- | -- |
| 10/23/2024 | Q3 | -- | $7.5B | $0.63 | -- | -- |
| 07/23/2024 | Q2 | -- | $6.7B | $0.54 | -- | -- |
| 04/23/2024 | Q1 | -- | $6.3B | $0.53 | -- | -- |
| 03/01/2024 | Q4 | -- | $6.4B | $0.49 | -- | -- |
| 10/25/2023 | Q3 | -- | $6.2B | $0.60 | -- | -- |
| 07/25/2023 | Q2 | -- | $6.6B | $0.75 | -- | -- |
| 04/25/2023 | Q1 | -- | $7.3B | $0.82 | -- | -- |
| 03/01/2023 | Q4 | -- | $9.1B | $0.78 | -- | -- |
| 10/25/2022 | Q3 | -- | $10.3B | $1.13 | -- | -- |
| 07/25/2022 | Q2 | -- | $10.9B | $1.30 | -- | -- |
| 04/26/2022 | Q1 | -- | $11B | $1.41 | -- | -- |
| 03/02/2022 | Q4 | -- | $11.9B | $1.30 | -- | -- |
| 10/20/2021 | Q3 | -- | $9.3B | $1.01 | -- | -- |
| 07/20/2021 | Q2 | -- | $8B | $0.80 | -- | -- |
| 04/26/2021 | Q1 | -- | $6.7B | $0.58 | -- | -- |
| 03/03/2021 | Q4 | -- | $6.1B | $0.39 | -- | -- |
| 10/20/2020 | Q3 | -- | $5.5B | $0.48 | -- | -- |
| 07/21/2020 | Q2 | -- | $5.1B | $0.29 | -- | -- |
| 03/31/2020 | Q1 | -- | $5.1B | $0.24 | -- | -- |
| 12/31/2019 | Q4 | -- | $5.3B | $0.34 | -- | -- |
| 09/30/2019 | Q3 | -- | $5.3B | $0.36 | -- | -- |
| 06/30/2019 | Q2 | -- | $5.3B | $0.34 | -- | -- |
| 03/31/2019 | Q1 | -- | $5.3B | $0.30 | -- | -- |
| 12/31/2018 | Q4 | -- | $5.4B | $0.32 | -- | -- |
| 09/30/2018 | Q3 | -- | $5.4B | $0.32 | -- | -- |
| 06/30/2018 | Q2 | -- | $5.3B | $0.35 | -- | -- |
| 03/31/2018 | Q1 | -- | $5.1B | $0.32 | -- | -- |
| 12/31/2017 | Q4 | -- | $5.1B | $0.34 | -- | -- |
| 09/30/2017 | Q3 | -- | $4.9B | $0.32 | -- | -- |
| 06/30/2017 | Q2 | -- | $4.6B | $0.33 | -- | -- |
| 03/31/2017 | Q1 | -- | $4.3B | $0.27 | -- | -- |
| 12/31/2016 | Q4 | -- | $4.3B | $0.31 | -- | -- |
| 09/30/2016 | Q3 | -- | $4.2B | $0.30 | -- | -- |
| 06/30/2016 | Q2 | -- | $4.3B | $0.32 | -- | -- |
| 03/31/2016 | Q1 | -- | $4B | $0.28 | -- | -- |
| 12/31/2015 | Q4 | -- | $4.3B | $0.28 | -- | -- |
Kühne + Nagel International AG reported $7.6B worth of top line sales in its most recent quarter.
Kühne + Nagel International AG announced earnings per share of $0.42 which represents a beat of analyst forecast a -- per share.
Kühne + Nagel International AG reported $808.5M that represents $1.39 per share over the last quarter.
Kühne + Nagel International AG's earnings are forecast to grow from $2.26 per share to -- per share next year representing an increase of --.
Kühne + Nagel International AG's next earnings date is March 3, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.